Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities

• Główni autorzy: Susanna Esposito (Autor), Stefano Zona (Autor), Andrea Pession (Autor), Lorenzo Iughetti (Autor), Giovanni Battista Migliori (Autor), Nicola Principi (Autor)
• Format: Książka
• Wydane: MDPI AG, 2021-07-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Monoclonal antibodies (mAbs) that neutralize SARS-CoV-2 in infected patients are a new class of antiviral agents approved as a type of passive immunotherapy. They should be administered to adults and children (≥12 years old, weighing ≥ 40 kg) with SARS-CoV-2 positivity, and who are suffering from a...